135 related articles for article (PubMed ID: 25828082)
1. Mitochondrial Carnitine/Acylcarnitine Translocase: Insights in Structure/Function Relationship.
Tonazzi A; Giangregorio N; Console L; Indiveri C
Mini Rev Med Chem; 2015 Apr; ():. PubMed ID: 25828082
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial carnitine/acylcarnitine translocase: insights in structure/ function relationships. Basis for drug therapy and side effects prediction.
Tonazzi A; Giangregorio N; Console L; Indiveri C
Mini Rev Med Chem; 2015; 15(5):396-405. PubMed ID: 25910653
[TBL] [Abstract][Full Text] [Related]
3. Localization of mitochondrial carnitine/acylcarnitine translocase in sensory neurons from rat dorsal root ganglia.
Tonazzi A; Mantovani C; Colella M; Terenghi G; Indiveri C
Neurochem Res; 2013 Dec; 38(12):2535-41. PubMed ID: 24104610
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of charged amino acids of the human mitochondrial carnitine/acylcarnitine carrier: insight into the molecular mechanism of transport.
Giangregorio N; Tonazzi A; Console L; Indiveri C; Palmieri F
Biochim Biophys Acta; 2010; 1797(6-7):839-45. PubMed ID: 20347717
[TBL] [Abstract][Full Text] [Related]
5. Dietary fat types differently modulate the activity and expression of mitochondrial carnitine/acylcarnitine translocase in rat liver.
Priore P; Stanca E; Gnoni GV; Siculella L
Biochim Biophys Acta; 2012 Oct; 1821(10):1341-9. PubMed ID: 22819991
[TBL] [Abstract][Full Text] [Related]
6. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits the mitochondrial carnitine/acylcarnitine carrier through reversible S-nitrosylation of cysteine 136.
Tonazzi A; Giangregorio N; Console L; De Palma A; Indiveri C
Biochim Biophys Acta Bioenerg; 2017 Jul; 1858(7):475-482. PubMed ID: 28438511
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of residues within the carnitine/acylcarnitine translocase RX2PANAAXF distinct motif.
De Lucas JR; Indiveri C; Tonazzi A; Perez P; Giangregorio N; Iacobazzi V; Palmieri F
Mol Membr Biol; 2008 Feb; 25(2):152-63. PubMed ID: 18307102
[TBL] [Abstract][Full Text] [Related]
9. A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting.
Sekoguchi E; Sato N; Yasui A; Fukada S; Nimura Y; Aburatani H; Ikeda K; Matsuura A
J Biol Chem; 2003 Oct; 278(40):38796-802. PubMed ID: 12882971
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
11. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformatics.
Tonazzi A; Eberini I; Indiveri C
PLoS One; 2013; 8(12):e82286. PubMed ID: 24349247
[TBL] [Abstract][Full Text] [Related]
14. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.
Violante S; Ijlst L; Te Brinke H; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
FASEB J; 2013 May; 27(5):2039-44. PubMed ID: 23322164
[TBL] [Abstract][Full Text] [Related]
15. Chymotrypsin activates cardiac mitochondrial carnitine-acylcarnitine translocase.
Wolkowicz PE; Pauly DF; Van Winkle WB; McMillin JB
Biochem J; 1989 Jul; 261(2):363-70. PubMed ID: 2505759
[TBL] [Abstract][Full Text] [Related]
16. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity.
Shi C; Ao Z; Liu B; Xiao X; Gu X; Yang Q; Hao H; Cai Y; Li S
Transl Pediatr; 2023 May; 12(5):871-881. PubMed ID: 37305732
[TBL] [Abstract][Full Text] [Related]
17. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
[TBL] [Abstract][Full Text] [Related]
18. Proline/Glycine residues of the PG-levels guide conformational changes along the transport cycle in the mitochondrial carnitine/acylcarnitine carrier (SLC25A20).
Giangregorio N; Pierri CL; Tonazzi A; Incampo G; Tragni V; De Grassi A; Indiveri C
Int J Biol Macromol; 2022 Nov; 221():1453-1465. PubMed ID: 36122779
[TBL] [Abstract][Full Text] [Related]
19. Dataset from dried blood spot acylcarnitine for detection of Carnitine-Acylcarnitine Translocase (CACT) deficiency and Carnitine Palmitoyl Transferase 2 (CPT2) deficiency.
Habib A; Nazri MIBA; Rahman SA
Data Brief; 2023 Jun; 48():109090. PubMed ID: 37020897
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acid residues underlying the antiport mechanism of the mitochondrial carnitine/acylcarnitine carrier by site-directed mutagenesis and chemical labeling.
Giangregorio N; Console L; Tonazzi A; Palmieri F; Indiveri C
Biochemistry; 2014 Nov; 53(44):6924-33. PubMed ID: 25325845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
